More Guidance Coming On Common Combo Product Designation Mistakes
Executive Summary
US FDA's Office of Combination Products hopes Q&A guidance will help lower high refusal rate on requests for designation.
You may also be interested in...
Final Combo Product GMP Requirements Are More Of The Same; Encourage FDA Meetings
A recent Federal Register Notice on GMP requirements for combination products doesn’t change any of the fundamental expectations and requirements laid out in a previous 2018 draft, but does add clarification for sponsors.
US FDA's Generics Program Reaches 'Steady State' Milestone
OGD Director Uhl says program is now in balance between the number of submissions and agency review actions.
Combo-Product Sponsors Could More Easily Get Device Designation At US FDA
Commissioner Gottlieb says upcoming guidance could help nudge products into preferred device realm if they are on cusp between drug or device jurisdictional designation.